| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 19,782 | | Cost of Revenue | 6,026 | | | Gross Profit | 13,756 | | | Operating Expenses | | Research Development | 3,843 | | Selling General and Administrative | 9,714 | | Non Recurring | (280) | | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 479 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,042 | | Earnings Before Interest And Taxes | 1,521 | | Interest Expense | 9 | | Income Before Tax | 1,512 | | Income Tax Expense | 21 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 1,491 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 1,491 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $1,491 |
|
1.48% Nasdaq 
Income Statement
